Swift Run Capital - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 24 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Swift Run Capital ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$17,000
+240.0%
20,000
+37.5%
0.03%
+385.7%
Q1 2020$5,000
-28.6%
14,5450.0%0.01%
-22.2%
Q4 2019$7,000
-74.1%
14,5450.0%0.01%
-64.0%
Q3 2019$27,000
-34.1%
14,5450.0%0.02%
-34.2%
Q2 2019$41,000
-24.1%
14,5450.0%0.04%
-24.0%
Q1 2019$54,000
+86.2%
14,5450.0%0.05%
+61.3%
Q4 2018$29,00014,5450.03%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Yu Fan 89,848$66,0000.75%
Virtu Financial LLC 285,621$209,0000.02%
GSA CAPITAL PARTNERS LLP 30,180$22,0000.00%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 43,868$32,0000.00%
Hoover Financial Advisors, Inc. 4,225$3,0000.00%
Renaissance Technologies 1,375,579$1,004,0000.00%
Frontier Wealth Management LLC 25,000$18,0000.00%
UBS Group AG 36,910$27,0000.00%
IFP Advisors, Inc 0$00.00%
OSAIC HOLDINGS, INC. 29,569$22,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders